BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $737,000 | +8.4% | 4,881 | +4.5% | 0.03% | +13.8% |
| Q2 2022 | $680,000 | +31.8% | 4,672 | +7.4% | 0.03% | +52.6% |
| Q1 2022 | $516,000 | -14.0% | 4,351 | 0.0% | 0.02% | -5.0% |
| Q4 2021 | $600,000 | -0.7% | 4,351 | 0.0% | 0.02% | -9.1% |
| Q3 2021 | $604,000 | +47.0% | 4,351 | +2.7% | 0.02% | +46.7% |
| Q2 2021 | $411,000 | +49.5% | 4,236 | +5.1% | 0.02% | +50.0% |
| Q1 2021 | $275,000 | -20.3% | 4,030 | 0.0% | 0.01% | -37.5% |
| Q4 2020 | $345,000 | +27.3% | 4,030 | -3.3% | 0.02% | +33.3% |
| Q3 2020 | $271,000 | -11.1% | 4,168 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $305,000 | +158.5% | 4,168 | +20.5% | 0.02% | +114.3% |
| Q1 2020 | $118,000 | -37.2% | 3,460 | 0.0% | 0.01% | -12.5% |
| Q4 2019 | $188,000 | +38.2% | 3,460 | +6.4% | 0.01% | +33.3% |
| Q3 2019 | $136,000 | +9.7% | 3,252 | +14.7% | 0.01% | 0.0% |
| Q2 2019 | $124,000 | -6.8% | 2,834 | +10.0% | 0.01% | 0.0% |
| Q1 2019 | $133,000 | +54.7% | 2,576 | +10.6% | 0.01% | +20.0% |
| Q4 2018 | $86,000 | -1.1% | 2,329 | 0.0% | 0.01% | +25.0% |
| Q3 2018 | $87,000 | -5.4% | 2,329 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $92,000 | +33.3% | 2,329 | -13.2% | 0.00% | +33.3% |
| Q1 2018 | $69,000 | +187.5% | 2,682 | +205.5% | 0.00% | +200.0% |
| Q4 2017 | $24,000 | -22.6% | 878 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $31,000 | +40.9% | 878 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $22,000 | – | 878 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |